Results 201 to 210 of about 157,438 (357)

Non-genetic factors associated with ACE-inhibitor and angiotensin receptor blocker-induced angioedema. [PDF]

Clin Transl Allergy
Dubrall D, Branding NL, Mathey CM, Weber AM, Steffens M, Below M, Schmid M, Wedi B, Wieczorek D, Amann PM, Löffler H, Koch L, Schöffl C, Dickel H, Ganjuur N, Hornung T, Buhl T, Aygören-Pürsün E, Wurpts G, Greve J, Nöthen MM, Forstner AJ, Sachs B.   +22 more
europepmc   +1 more source

Beta-blocker/ACE inhibitor therapy differentially impacts the steady state signaling landscape of failing and non-failing hearts. [PDF]

Sci Rep, 2022
Sorrentino A, Bagwan N, Linscheid N, Poulsen PC, Kahnert K, Thomsen MB, Delmar M, Lundby A.   +7 more
europepmc   +1 more source

Chimeric diphtheria toxin–CCL8 cytotoxic peptide for breast cancer management

Molecular Oncology, EarlyView.
DTCCL8 is a recombinant fusion toxin that targets cancer cells expressing chemokine receptors. By combining diphtheria toxin with CCL8, DTCCL8 binds to multiple receptors on tumor cells and induces selective cytotoxicity. This strategy enables receptor‐mediated targeting of cancer and may support the development of chemokine‐guided therapeutics ...
Bernardo Chavez, Asieh Naderi, Kim‐Tuyen Huynh‐Dam, Vitali Sikirzhytski, Ioulia Chatzistamou, Hippokratis Kiaris   +5 more
wiley   +1 more source

Effects of the ACE Inhibitor, Perindoprilat, and of Angiotensin II on the Transient Inward Current of Guinea Pig Ventricular Myocytes

, 1992
R. Enous, William A. Coetzee, Lionel H. Opie   +2 more
openalex   +1 more source

SUBGLOTTIC STENOSIS: AN UNUSUAL PRESENTATION OF ACE INHIBITOR‐INDUCED ANGIOEDEMA [PDF]

, 1999
David Martín, Roger Grigg, A. Tomkinson, William B. Coman   +3 more
openalex   +1 more source

Angioedema, ACE inhibitor and COVID-19. [PDF]

BMJ Case Rep, 2020
Grewal E, Sutarjono B, Mohammed I.
europepmc   +1 more source

ACE-inhibitor/angiotensin receptor blockers (ACE-I/ARBs) therapy in COVID-19 infected dialysis patients. [PDF]

Ren Fail, 2021
Daoud A, Ali H, Rao V, Rohan V, Soliman K.   +4 more
europepmc   +1 more source

ITGAV and SMAD4 influence the progression and clinical outcome of pancreatic ductal adenocarcinoma

Molecular Oncology, EarlyView.
In SMAD4‐positive pancreatic ductal adenocarcinoma (PDAC), integrin subunit alpha V (ITGAV) activates latent TGF‐β, which binds to the TGF‐β receptor and phosphorylates SMAD2/3. The activated SMAD2/3 forms a complex with SMAD4, and together they translocate to the nucleus, modulating gene expression to promote proliferation, migration, and invasion. In
Daniel K. C. Lee, Keyue Chen, Ryan Loke, Xiang Li, David Liubart, Golam T. Saffi, Jonathan T. S. Chow, Ché M. P. Melo, Lydia To, Leonardo Salmena   +9 more
wiley   +1 more source

Angiotensin-Converting Enzyme (ACE)-Inhibitor Activity of Novel Peptides Derived from Porcine Liver and Placenta. [PDF]

Molecules
Pearman NA, Morris GA, Smith AM.
europepmc   +1 more source

ACE inhibitor-related angioedema in a COVID-19 patient-a plausible contribution of the viral infection? [PDF]

Eur J Clin Pharmacol, 2021
Kuzemczak M, Kavvouras C, Alkhalil M, Osten M.   +3 more
europepmc   +1 more source